Professor Minna Nyström (prev. Nyström-Lahti), PhD Founder & Chairman of the Board Minna is the leading inventor of DiagMMR with more than 30 years of experience in the field of Lynch syndrome research. She has had an active role in both the identification of the LS-related genes and mutations, as well as the improvement of […]
Niklas Lahti MSc Chief Executive Officer Niklas is responsible for operational and financial management, investor relations, and shareholder management at Lynsight. He is a corporate finance professional with a background in M&A and capital restructurings. Niklas joined Lynsight in 2017 as the CFO and was appointed as CEO in 2022.
Minttu Kansikas <smallPhD Chief Scientific Officer Minttu has worked on Lynch syndrome research for over 10 years and is a co-inventor of DiagMMR. Her doctoral thesis, “Recognizing Lynch syndrome by DNA mismatch repair deficiency” focused on the functional detection of reduced mismatch repair and the pathogenicity assessment of found LS variants. She is responsible for […]
Chief Scientific Officer
Minttu has worked on Lynch syndrome research for over 10 years and is a co-inventor of DiagMMR. Her doctoral thesis, “Recognizing Lynch syndrome by DNA mismatch repair deficiency” focused on the functional detection of reduced mismatch repair and the pathogenicity assessment of found LS variants. She is responsible for the laboratory operations, scientific research and product development at LS CancerDiag.
